Arubendol-betha-2-agonist in therapy of patients with bronchial
Abstract
The therapeutic effect of arubendol (terbutaline sulfate) was studied in patients with BA of atopic form primarily with moderate currence in degree of moderate exacerbation. The drug was administered in doses of 1—2 mg per day. In most patients (25 among of 30 ones) the positive therapeutic effect was obtained. The undesired side effects noted in 16 patients were not severe and weren't as the cause for ancelling the medication. The betha-2-agonist arubendol medication may be concidered as an effective therapy in patients BA of mild and moderate exacerbation phase.
About the Authors
I. G. Daniliak
ММА им. И. М. Сеченова
Russian Federation
Russian Federation
V. Y. Snifaaaeitico
ММА им. И. М. Сеченова
Russian Federation
Russian Federation
T. P. Guseva
ММА им. И. М. Сеченова
Russian Federation
Russian Federation
A. A. Stremoukhov
ММА им. И. М. Сеченова
Russian Federation
Russian Federation
References
1. Даниляк И. Г. Современная фармакотерапия больных бронхиальной астмой: Дис. ... д-ра. мед. наук.— М., 1983.
2. Замотаев И. П. Клиническая фармакология бронхолитиков и тактика их применения.— М., 1979.— С. 23.
3. Лоуренс Д. Р., Беннит П. И. Клиническая фармакология.М., 1991.— T. 2.— С. 322.
4. Максимова Л. И. Клиническая фармакология дозированных аэрозолей новых бронхорасширяющих средств: Автореф. дис. ... канд. мед. наук.— М., 1974.
5. Цой А. Н. Клиническая фармакология бронхорасширяющих лекарственных средств: Дис. ... д-ра мед. наук.— М., 1990.— С. 88—90.
6. Чучалин А. Г. Бронхиальная астма.— М., 1985.— С. 94.
7. Johnsen С. R., Weeke Е. R. Turbuhaler — a new device for dry powder turbutaline sulfate inhalation: therapeutic effect in comparison with metered dose inhaler in adults // International Workshop Proceedings.— London, 1987.— P. 131 — 135.
8. Mollarkey G. Terbutaline inhalation therapy in asthma.— Manchester, 1989.— P. 1—3; 13.
9. Persson G., Gruvstad E., Wiren J. E. Therapeutic effect of Turbuhaler in comparison with metered dose inhaler in adults // International Workshop Proceedings.— London, 1987.— P. 136—141.
Review
For citations:
Daniliak I.G., Snifaaaeitico V.Y., Guseva T.P., Stremoukhov A.A. Arubendol-betha-2-agonist in therapy of patients with bronchial. PULMONOLOGIYA. 1993;(1):65-67. (In Russ.)
Views:
115
Email this article 